A marketing company can sell its own branded ophthalmic products through eye drops third party manufacturing in Gujarat, while a licensed, GMP-compliant plant makes them. The manufacturer handles formulation, sterile filling, testing and packing. You keep branding, sales and distribution. PCD companies, distributors and exporters find it a good fit, and Gujarat is usually the first stop because of its dense pharma clusters, its supplier network and a drug regulator that stays active.
This guide covers how the model works, which products you can launch, which licenses you need, what it costs and how to shortlist a partner. Every section stands on its own, so skip to whatever you need.
In this guide:
- What is eye drops third party manufacturing?
- Why choose Gujarat?
- Ophthalmic product types
- What makes a good partner
- Licenses and documents
- Step-by-step process
- Packaging and branding
- How to choose a manufacturer
- Cost
- Challenges
- Market opportunity
- FAQs
What Is Eye Drops Third Party Manufacturing?
Third-party manufacturing for eye drops is a contract deal. A licensed manufacturer makes sterile ophthalmic formulations, and you sell them under your own brand. The plant, the production staff, the cleanrooms: none of that is yours to run. They build to the specs you agree on, and you hold the trademark and do the marketing.
How Third Party Ophthalmic Manufacturing Works?
Here’s how it works. You pick the products and brand names. The manufacturer finalises the formulation, buys the raw materials, fills under aseptic conditions, tests the batch and packs it in your branded cartons. Finished stock goes to your warehouse or distributors, with a Certificate of Analysis (COA) for every batch.
Eye drops have to be sterile, so most of the technical risk sits with the manufacturer. That’s why ophthalmic products manufacturers in Gujarat with dedicated sterile lines are worth far more to you than a general tablet or syrup plant.
Third Party vs Loan License vs Own Manufacturing Unit
| Factor | Third party manufacturing | Loan license | Own plant |
|---|---|---|---|
| Investment | Low (product, packaging and stock costs) | Medium (license fees plus equipment access charges) | Very high (land, cleanrooms, machinery, staff) |
| Control | Moderate (formula and brand are yours, process is theirs) | High (your team oversees production at the licensee’s site) | Full |
| Timeline | Weeks to a few months | Several months | 18 to 36 months or more |
| Risk | Low to moderate (depends on partner quality) | Moderate | High (capital and compliance risk) |
| Best for | New and mid-size marketers, PCD firms, distributors | Established brands wanting tighter control | Large pharma with high, stable volumes |
Why Choose Gujarat for Third Party Eye Drop Manufacturing?
Gujarat is a preferred hub for a simple reason: the pharma ecosystem is already here, the state regulator responds quickly, and the supply chain is solid. Sterile manufacturing needs steady utilities, trained technicians and dependable suppliers of vials, droppers and excipients. Most states struggle to offer that mix, but Gujarat usually does.
Gujarat’s Pharma Ecosystem (Ahmedabad, Vadodara, Baroda, Ankleshwar, Mehsana Clusters)
Gujarat is widely said to account for roughly a quarter to a third of India’s pharmaceutical output (check the latest figure against Gujarat government or Pharmexcil data before publishing). The main clusters include:
- Ahmedabad and Changodar/Sanand belts: formulation units, packaging suppliers, testing labs.
- Vadodara (also written Baroda): strong formulation and API presence. These are the same city, so list it once on your page.
- Ankleshwar: chemical and API strength, useful for raw material access.
- Mehsana: a growing formulation cluster with newer sterile facilities.
Regulatory Support and FDCA Gujarat Oversight
Licenses to manufacture in Gujarat are issued and monitored by the Food and Drug Control Administration (FDCA), Gujarat, which works alongside the central regulator, CDSCO. Manufacturers have to meet the Revised Schedule M GMP requirements under the Drugs and Cosmetics Rules. If your partner has had recent FDCA inspections and a clean audit record, your compliance risk drops.
Cost, Raw Material and Logistics Advantages
The ports at Mundra, Kandla and Pipavav are close, which helps exporters. Glass, LDPE bottles, cartons and excipients are all sourced nearby, so lead times and freight shrink. Labour and utilities are competitively priced, and that often means a better per-unit price than in many other states.
Gujarat’s Advantages at a Glance
- Large concentration of WHO-GMP and export-oriented plants
- Dense supplier network for packaging and excipients
- Access to major ports for export shipments
- Experienced sterile-manufacturing workforce
- Active state regulator (FDCA Gujarat) and quick license support
- Strong logistics links to north, west and south India
Types of Ophthalmic Products Made by Third Party Manufacturers in Gujarat
Ophthalmology Products Manufacturers in Gujarat: Product Range Overview
Ophthalmology products manufacturers in Gujarat usually make solutions, suspensions, gels, ointments and unit-dose vials. The better ones already hold a portfolio of common molecules, so you can launch in weeks instead of paying for a new formulation.
Lubricant and Artificial Tear Eye Drops
These handle dry eye and the irritation that comes from long screen hours. Carboxymethylcellulose, hydroxypropyl methylcellulose and sodium hyaluronate are the usual actives. They move well in the OTC-adjacent space, which is why most new brands start here.
Antibiotic, Anti-Inflammatory and Steroid Eye Drops
Think bacterial conjunctivitis, post-surgical care and inflammation. Moxifloxacin, ofloxacin, tobramycin and prednisolone (alone or in combination) are typical. They’re prescription-only, so you’ll need to put your marketing effort into doctors.
Anti-Glaucoma Eye Drops
These bring intraocular pressure down, using timolol, brimonidine, dorzolamide, latanoprost and their combinations. Patients stay on them for years, and that means steady repeat prescriptions.
Anti-Allergy and Antihistamine Eye Drops
Olopatadine and ketotifen cover seasonal and allergic conjunctivitis. Demand spikes with the seasons, so schedule your batches before the pollen and dust periods begin.
Preservative-Free and Single-Dose (Unit-Dose) Eye Drops
Dry eye patients, contact lens wearers and post-op cases do best with these. Filling them needs advanced sterile technology like blow-fill-seal (BFS) or form-fill-seal, so check that your manufacturer actually has it before you commit.
Eye Ointments, Gels and Other Ophthalmic Formulations
They stay on the eye longer, which is why they’re mostly used at night. The filling equipment is separate, so ask whether they make these in-house or outsource them.
Product Category Table
| Category | Common molecules | Typical packaging | Prescription status |
|---|---|---|---|
| Lubricants / artificial tears | CMC, HPMC, sodium hyaluronate | 5–10 ml LDPE bottle; unit-dose vials | Mostly OTC |
| Antibiotic | Moxifloxacin, ofloxacin, tobramycin | 5–10 ml bottle | Rx |
| Steroid / anti-inflammatory | Prednisolone, loteprednol, ketorolac | 5–10 ml bottle | Rx |
| Anti-glaucoma | Timolol, brimonidine, latanoprost | 2.5–5 ml bottle | Rx |
| Anti-allergy | Olopatadine, ketotifen | 5 ml bottle | Rx / some OTC |
| Preservative-free | Lubricants, some antibiotics | Unit-dose (BFS) vials | Varies |
| Ointments and gels | Antibiotic or lubricant bases | 3–5 g tube | Rx / OTC |
Third Party Eye Drop Manufacturers in Gujarat: What Makes a Good Partner?
A good partner shows sterile competence through paperwork, infrastructure and test data. Promises don’t count. Here are the four areas to judge them on.
Ophthalmic Manufacturing Standards (Revised Schedule M, WHO-GMP, ISO)
They should meet Revised Schedule M, and hold WHO-GMP certification if you plan to export or supply institutions. ISO 9001 helps too, since it shows their processes are documented. Don’t stop at the certificate; ask to see the latest inspection outcomes.
Sterile Manufacturing Infrastructure (Aseptic Filling, BFS, Cleanrooms)
Look for graded cleanrooms, HEPA filtration, validated aseptic filling lines and environmental monitoring. BFS technology is a plus for unit-dose products. Ask what their media fill (process simulation) results looked like.
R&D, Formulation Support and Stability Testing
The stronger partners develop formulations in-house and run stability studies to ICH guidelines. This matters if you want custom combinations or preservative-free versions.
In-House QC/QA and Microbiology Lab
Testing. Sterility, bacterial endotoxin and particulate checks should be done in-house or at an accredited lab. Also ask whether QA can reject a batch on its own authority.
Manufacturer Evaluation Checklist
- Valid manufacturing license covering ophthalmic preparations
- Revised Schedule M compliance evidence
- WHO-GMP certificate (current)
- Dedicated sterile area and validated aseptic or BFS line
- In-house QC, microbiology and stability facility
- Batch-wise COA and retention samples
- Clean recent inspection history
- Ability to customise formulation and packaging
- Transparent MOQ, pricing and lead times
- References from existing clients
Licenses and Documents Required for Ophthalmic Third Party Manufacturing?
Both sides need valid paperwork, and missing documents are the most common reason launches get pushed back.
Documents the Marketing Company Must Have (Drug License, GST, Trademark)
On your end, that means a drug license or wholesale license (whichever applies to you), GST registration, and a trademark that’s registered or at least applied for. Keep your PAN, business registration proof and address proof handy too.
Documents the Manufacturer Must Provide (Manufacturing License, WHO-GMP, COA, Product Permissions)
The manufacturer should hand over its manufacturing license, GMP certificates, batch COAs, product permissions, and technical dossiers. Ask for copies before you sign anything.
Product Permissions and Composition Approvals
One more thing. Every formulation must fall under the manufacturer’s license, and a new combination may need regulatory approval before it can be sold commercially. Get that confirmed in writing.
| You provide | Manufacturer provides |
|---|---|
| Drug or wholesale license | Manufacturing license (Form 25/28 category as applicable) |
| GST registration | WHO-GMP / Revised Schedule M evidence |
| Trademark registration or application | Product permissions and composition approvals |
| Artwork and brand details | Batch COA and stability data |
| Purchase order and agreement | Technical documents and MSDS |
Step-by-Step Process to Start Eye Drops Third Party Manufacturing in Gujarat
- Shortlist products: Choose 3–5 molecules based on your target doctors and territories.
- Verify the manufacturer: Check licenses, inspection history and a facility visit.
- Finalise the formulation: Agree on composition, preservative system and strength.
- Design packaging: Approve bottle type, label and carton artwork.
- Sample and stability: Review samples and stability data before committing.
- Trial batch: Produce a small batch to confirm quality and appearance.
- Commercial batch: Scale to full production once the trial passes.
- Dispatch: Receive stock with COA, invoices and transport documents.
Timeline from Enquiry to First Batch
Ready-made formulations can usually reach a first commercial batch in 6 to 12 weeks, depending on artwork approval and testing. Custom formulations or new permissions take longer, often several months.
Minimum Order Quantity (MOQ) and Pricing Factors
MOQ varies with the filling line, pack size and formulation. Sterile products tend to need bigger minimums than oral ones, since batch setup and testing cost more. Price depends on the actives, the packaging, your volume and the sterilisation method. Get the MOQ in writing for each SKU.
Packaging, Branding and Private Label Options for Ophthalmic Products
Bottle Types, Labelling and Carton Design
Most eye drops go into LDPE or HDPE dropper bottles, sometimes with tamper-evident caps. Unit-dose vials come off BFS lines. Keep the labels clear: strength, storage, and how long the drops can be used once opened.
Trademark and Brand Protection
Register your brand name before you place an order. Also put a clause in the agreement that stops the manufacturer from selling your formulation or brand to anyone else.
Ophthalmic Packaging Compliance (Labelling, Batch Coding, Shelf Life)
Every label needs the batch number, manufacturing and expiry dates, manufacturer details, storage conditions and any required warnings. Shelf life has to be backed by stability data, and the in-use period after opening should be stated plainly.
How to Choose the Right Ophthalmic Products Manufacturer in Gujarat?
10 Questions to Ask Before Signing an Agreement
- Which licenses and certifications do you hold, and when do they expire?
- Do you have a dedicated sterile ophthalmic line?
- Can I audit your facility and QC lab?
- What is your MOQ per SKU?
- Who owns the formulation and dossier?
- What is your batch rejection and recall policy?
- How long do trial and commercial batches take?
- Can you support unit-dose or preservative-free formats?
- What stability data can you share?
- Can I speak with two existing clients?
Red Flags to Avoid
- Unwillingness to allow a facility audit
- No dedicated sterile area
- Very low prices with vague specifications
- Missing or expired licenses
- No batch-wise COA
- Refusal to put terms in writing
Manufacturer Scoring Rubric
Score each factor from 1 (poor) to 5 (excellent), then apply the weights.
| Criteria | Weight | What to check | Score (1–5) |
|---|---|---|---|
| Compliance | 30% | Schedule M, WHO-GMP, inspection history | |
| Capacity | 20% | Sterile line size, BFS, batch scalability | |
| Support | 20% | Formulation help, regulatory guidance | |
| Pricing | 15% | Transparent, competitive, no hidden fees | |
| Turnaround | 15% | Lead times, dispatch reliability |
A weighted total above 4.0 indicates a strong candidate.
Cost of Eye Drops Third Party Manufacturing in Gujarat
Factors That Influence Pricing (Formulation, Packaging, Volume, Sterility Method)
Four things move the price of eye drops more than anything else. The active ingredient sets the base cost. Packaging (bottle, cap, label, carton) is next. Order volume brings the per-unit rate down. The sterility method, whether terminal sterilisation, aseptic filling or BFS, changes what you pay for machines and for testing.
Sample Cost Structure (Indicative)
| Cost component | Indicative share of manufacturing price | Notes |
|---|---|---|
| Active ingredients | 20–40% | Higher for glaucoma and steroid drops |
| Excipients and solvents | 5–10% | Water for injection, buffers, preservatives |
| Primary packaging (bottle, cap) | 15–25% | Higher for unit-dose vials |
| Secondary packaging (label, carton) | 8–15% | Depends on print quality |
| Sterile processing and QC | 15–25% | Cleanroom, testing, validation |
| Manufacturer margin | 10–20% | Varies by volume |
These ranges are indicative only. Request a formal quotation for actual pricing.
Challenges in Ophthalmic Contract Manufacturing and How to Avoid Them
Sterility and Contamination Risk
Eye drops have to be sterile, and sloppy aseptic practice is how infections happen. Before you sign with a manufacturer, go through their cleanroom controls, media fill records and environmental monitoring data yourself.
Stability, Preservatives and Shelf Life
Some actives break down fast, and preservatives can sting or irritate. Ask for stability data under ICH conditions. For sensitive users, preservative-free is worth considering.
Regulatory Delays and Batch Rejections
Paperwork gaps, unapproved compositions and failed tests are what hold up dispatch. Confirm permissions at the start, and run a trial batch before you scale.
Market Opportunity: Why Ophthalmology Is a Growing Segment for Pharma Marketers
Demand Drivers (Digital Eye Strain, Ageing Population, Diabetic Eye Disease)
Demand isn’t going anywhere. Long screen hours are pushing up dry eye and irritation cases, an ageing population means more cataract, glaucoma and dry eye, and India’s large diabetic population carries a real risk of diabetic retinopathy. [Add a current statistic with citation here, e.g. from the Ministry of Health’s national blindness survey or an IAPB/WHO report.]
Who Benefits (PCD Companies, Distributors, Institutional Suppliers, Exporters)
- PCD companies gain a specialist range that opens doctor-level conversations.
- Distributors add a higher-margin, repeat-use category.
- Institutional suppliers serve eye hospitals and chains.
- Exporters can use WHO-GMP-backed products for regulated and semi-regulated markets.
Why Work With Ophtha Vends , a Trusted Third Party Ophthalmology Manufacturer in Gujarat?
Our Facility and Certifications
Ophtha Vends offer a WHO-GMP / Revised Schedule M-compliantfacility in Gujarat, runs dedicated sterile ophthalmic lines [with BFS capability, if applicable], and every batch goes through our own QC and microbiology lab.
Product Range and Customisation
We make ophthalmic formulations: lubricants, antibiotics, steroids, anti-glaucoma, anti-allergy and preservative-free. Custom packaging and private-label branding come with it.
Conclusion
Getting eye drops made by a third party in Gujarat is the quickest way to launch a branded ophthalmic range without tying up much capital. Pick your partner for compliance, sterile capability and how open they are with you. Price alone is a poor reason.
- Contract manufacturing costs far less than setting up your own plant or buying a loan license.
- Gujarat’s clusters, suppliers and regulator support get you to a compliant launch sooner.
- Check the licenses, audit the sterile area yourself, and run a trial batch first.
Next step: request a quote, download the product catalogue or message us on WhatsApp to shortlist your first ophthalmic range.
Frequently Asked Questions
What is eye drops third party manufacturing?
It is a contract model where a licensed manufacturer produces sterile eye drops under your brand. You market and sell the products, while the manufacturer handles formulation, filling, testing and packaging. It removes the need to own a plant and lowers upfront investment.
Why is Gujarat a good place for third party eye drop manufacturing?
Gujarat has a dense pharma belt, and that matters. Sterile-trained staff are easier to find, packaging and excipient suppliers are close by, the ports are nearby, and FDCA Gujarat is an active regulator. Lead times shrink, compliance is easier to manage, and costs often come in lower than in less developed hubs.
What licenses do I need to start ophthalmic third party manufacturing?
You’ll need a drug or wholesale license, GST registration and a trademark. Your manufacturer needs a valid manufacturing license that specifically covers ophthalmic products, plus GMP evidence and product permissions. Check every document before you sign anything.
What is the minimum order quantity for eye drops?
MOQ isn’t fixed. It shifts with the manufacturer, pack size and filling method, and sterile batches usually run higher than oral ones because setup and testing cost so much. Get a per-SKU MOQ in writing, and ask whether a smaller trial batch is possible.
How long does it take to launch eye drops through a third party manufacturer?
For a ready formulation, expect roughly 6 to 12 weeks to your first commercial batch, depending on artwork approval, sampling and testing. Custom formulations or new permissions take longer. Treat these as ballpark figures and lock the timeline into the agreement.
How do I choose a reliable ophthalmic manufacturer in Gujarat?
Start with licenses, Revised Schedule M and WHO-GMP status, then look at sterile infrastructure, in-house QC and inspection history. Visit the plant. Ask for batch COAs and talk to current clients. Then score your shortlist on a weighted rubric so the comparison isn’t just gut feel.